Skip to main content

Advertisement

SpringerLink
Log in

Treatment of pediatric multiple sclerosis

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

An increasing number of children and adolescents with multiple sclerosis (MS) are being identified and treated with disease-modifying therapies. Yet, there currently is little experience to guide clinicians. As more rapid diagnosis is made possible with magnetic resonance imaging, the number of pediatric MS patients requiring treatment will increase with time. This review draws on information from adult and pediatric neurology sources and summarizes current available data. Additional research is clearly needed. Nonetheless, there are several treatment principles: 1) establishing the diagnosis by differentiating MS from acute disseminated encephalomyelitis or recurrent acute disseminated encephalomyelitis; 2) emphasizing that there are parallels between adult and pediatric MS regarding the clinical presentation, disease course, and ability to tolerate therapy (the more extensive experience in adult MS can be applied to most pediatric cases); 3) explaining the importance of starting treatment early in the disease course and that these therapies seem well-tolerated in children; 4) providing reassurance that the family is not alone; as approximately 5% of the MS population has symptom onset before age 18 years (experience with pediatric MS is growing and centers with pediatric MS programs exist in other countries and are developing within the United States); and 5) reviewing symptom management and addressing issues such as academic performance that are unique to the pediatric MS subpopulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ghezzi A, Deplano V, Faroni J, et al.: Multiple sclerosis in childhood: Clinical features of 149 cases. Mult Scler 1997, 3:43–46.

    Article  PubMed  CAS  Google Scholar 

  2. Boiko A, Vorobeychik G, Devonshire V, et al.: Early onset multiple sclerosis a longitudinal study. Neurology 2002, 59:1006–1010. This study describes the presenting symptoms, clinical course, and prognosis of 116 children with MS who were followed up for a mean of 19.8 years.

    Article  PubMed  CAS  Google Scholar 

  3. Simone IL, Carrara D, Tortorella C, et al.: Course and prognosis in early-onset MS -Comparison with adult-onset forms. Neurology 2002, 59:1922–1928. This comparison between 83 children and 710 adults with MS identifies differences and similarities among patients followed over a course for a mean of 5 years.

    PubMed  CAS  Google Scholar 

  4. Poser CM, Paty DW, Scheinberg L, et al.: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983, 13:227–231.

    Article  PubMed  CAS  Google Scholar 

  5. Mikaeloff Y, Moreau T, Debouverie M, et al.: Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 2001, 139:443–446.

    Article  PubMed  CAS  Google Scholar 

  6. McDonald WI, Compston A, Edan G, et al.: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121–127.

    Article  PubMed  CAS  Google Scholar 

  7. Hahn CD, Shroff MM, Blaser SI, Banwell BL: MRI criteria for multiple sclerosis — Evaluation in a pediatric cohort. Neurology 2000, 62:806–808. This study determined whether MRI studies among 20 patients with clinically defined childhood onset MS met criteria for a positive MRI as proposed in 2001 by an international panel of experts in MS [6].

    Google Scholar 

  8. Tenembaum S, Chamoles N, Fejerman N: Acute disseminated encephalomyelitis—A long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224–1231. This thorough description of 84 pediatric patients with ADEM and its variants examines their long term course and identifies difference from MS even among those patients with ADEM who had more than one attack.

    PubMed  Google Scholar 

  9. Alper G, Schor NF: Toward the definition of acute disseminated encephalitis of childhood. Curr Opin Pediatr 2004, 16:637–640.

    Article  PubMed  Google Scholar 

  10. Tardieu M, Mikaeloff Y: What is acute disseminated encephalomyelitis (ADEM)? Euro J Paediatr Neurol 2004, 8:239–242.

    Article  Google Scholar 

  11. Mikaeloff Y, Adamsbaum C, Husson B, et al.: MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004, 127:1942–1947. This well-designed, large, multi-center study examined 296 children with an initial demyelinating event and their subsequent course over 2.9 years. The study included patients initially labeled as ADEM and subsequently reclassified as MS and patients who initially were classified as MS. Unfortunately, explanations of why patients were initially classified as either ADEM or MS were not provided.

    Article  PubMed  Google Scholar 

  12. Dale RC, de Sousa C, Chong WK, et al.: Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000, 123:2407–2422.

    Article  PubMed  Google Scholar 

  13. Gadoth N: Multiple sclerosis in children. Brain Dev 2003, 25:229–232.

    PubMed  Google Scholar 

  14. Hynson JL, Kornberg AJ, Coleman LT, et al.: Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308–1312.

    PubMed  CAS  Google Scholar 

  15. Lennon VA, Wingerchuk DM, Kryzer TJ, et al.: A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106–2112.

    Article  PubMed  CAS  Google Scholar 

  16. Natowicz MR, Bejjani B: Genetic disorders that masquerade as multiple sclerosis. Am J Med Genet 1994, 49:149–169.

    Article  PubMed  CAS  Google Scholar 

  17. Mcadam LC, Blaser SI, Banwell BL: Pediatric tumefactive demyelination: Case series and review of the literature. Pediatric Neurology 2002, 26:18–25.

    Article  PubMed  Google Scholar 

  18. Ruggieri M, Polizzi A, Pavone L, Grimaldi LM: Multiple sclerosis in children under 6 years of age. Neurology 1999, 53:478–484.

    PubMed  CAS  Google Scholar 

  19. Waubant E, Hietpas J, Stewart T, et al.: Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 2001, 32:211–213.

    Article  PubMed  CAS  Google Scholar 

  20. Pohl D, Rostasy K, Hanefeld F, Gartner J: The use of interferon beta 1a (Rebif) in children and adolescents with multiple sclerosis. Mult Scler 2004, 10(Suppl 2):S250.

    Google Scholar 

  21. Krupp LB, Banwell B, Boiko A, et al.: Treatment of childhood and adolescent MS with interferon beta 1b. Mult Scler 2004, 10(Suppl 2):S245.

    Google Scholar 

  22. Adams AB, Tyor WR, Holden KR: Interferon beta 1b and childhood multiple sclerosis. Pediatr Neurol 1999, 21:481–483.

    Article  PubMed  CAS  Google Scholar 

  23. Krupp LB, Pardo L, Vitt D: Clinical features and disease-modifying therapy experience in paediatric multiple sclerosis. Mult Scler 2004, 10(Supple 2):S178.

    Google Scholar 

  24. Kornek B, Bernert G, Balassy C, et al.: Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics 2003, 34:120–126.

    Article  PubMed  CAS  Google Scholar 

  25. Hahn S, Siegler DJ, Enzmann D: Intravenous gammaglobulin therapy in latent acute disseminated encephalomyelitis [abstract]. Am Acad Neurol 1996, 1173–1174.

  26. Weinshenker BG, O’Brien PC, Petterson TM, et al.: A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999, 46:878–886.

    Article  PubMed  CAS  Google Scholar 

  27. Takahashi I, Sawaishi Y, Takeda O, et al.: Childhood multiple sclerosis treated with plasmapheresis. Pediatr Neurol 1997, 17:83–87.

    Article  PubMed  CAS  Google Scholar 

  28. MacAllister WS, Belman AL, Milazzo M, et al.: Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005, In press.

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, State University of New York at Stony Brook, HSC T-12-033, 11794, Stony Brook, NY, USA

    Lauren B. Krupp MD

Authors
  1. Lauren B. Krupp MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William S. MacAllister PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krupp, L.B., MacAllister, W.S. Treatment of pediatric multiple sclerosis. Curr Treat Options Neurol 7, 191–199 (2005). https://doi.org/10.1007/s11940-005-0012-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-005-0012-4

Keywords

Search

Navigation